Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of genetic features on treatment decisions in AML.

Hematology. American Society of Hematology. Education Program - 1 Jan 2011

Döhner Hartmut, Gaidzik Verena I

Abstract excerpt

In recent years, research in molecular genetics has been instrumental in deciphering the molecular pathogenesis of acute myeloid leukemia (AML). With the advent of the novel genomics technologies such as next-generation sequencing, it is expected that virtually all genetic lesions in AML will soo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Biomarkers, Tumor
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Neoplasm

Share to Histone Deacetylase Inhibitors Research

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Protein Degradation and Inhibitors

Source

Identifiers

PMID: 22160010
DOI: 10.1182/asheducation-2011.1.36

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22160010-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of genetic features on treatment decisions in AML.PMID 22160010Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

Genetic mutations in acute myeloid leukemia that influence clinical decisions.Semantic proximity Read ↗

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia.Semantic proximity Read ↗

The impact of mutational profiling on AML prognosis.Semantic proximity Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Molecular genetic pathways as therapeutic targets in acute myeloid leukemia.Semantic proximity Read ↗

The changing paradigm of prognostic factors in acute myeloid leukaemia.Semantic proximity Read ↗

What do functional genomics tell us about pathogenesis of AML?Semantic proximity Read ↗

Clinical implications of molecular markers in acute myeloid leukemia.Semantic proximity Read ↗

The Evolving AML Genomic Landscape: Therapeutic Implications.Semantic proximity Read ↗

Classification and risk assessment in AML: integrating cytogenetics and molecular profilingSemantic proximity Read ↗

Integrating genomics into prognostic models for AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.